Contraception
Volume 81, Issue 1 , Pages 62-66 , January 2010

Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision

  • Guoyun Wang

      Affiliations

    • Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan 250012, People's Republic of China
    • Corresponding Author InformationCorresponding author. Tel.: +86 531 82169565; fax: +86 531 82169200.
    • G.W. and D.L. contributed equally to this work.
    • ,
  • Dong Li

      Affiliations

    • Laboratory of Cryomedicine, Qilu Hospital of Shandong University, Jinan 250012, People's Republic of China
    • G.W. and D.L. contributed equally to this work.
    • ,
  • Frank Manconi

      Affiliations

    • Department of Obstetrics and Gynecology, Queen Elizabeth II Research Institute for Mothers and Infants, University of Sydney, Sydney, NSW 2006, Australia
    • ,
  • Baihua Dong

      Affiliations

    • Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan 250012, People's Republic of China
    • ,
  • Yuncun Zhang

      Affiliations

    • Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan 250012, People's Republic of China
    • ,
  • Bingcui Sun

      Affiliations

    • Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan 250012, People's Republic of China

Received 17 December 2008 ,Revised 23 September 2009 ,Accepted 24 September 2009.

References 

  1. Wu Y. Medical progress in China — family planning. Natl Med J China. 1995;75:749–751
  2. Moreno-Ruiz NL, Borgatta L, Yanow S, Kapp N, Wiebe ER, Winikoff B. Alternatives to mifepristone for early medical abortion. Int J Gynaecol Obstet. 2007;96:212–218
  3. Xu J, Chen H, Ma T, Wu X. Termination of early pregnancy in the prior uterine incision with mifepristone and misoprostol. Int J Gynaecol Obstet. 2001;72:245–251
  4. Gao P, Wang P. Clinical observation on termination of early pregnancy of 213 cases after caesarian section with repeated use of mifepristone and misoprostol. J Reprod Contracept. 1999;10:227–233
  5. The RU 486 Collaboration Group. Termination of early pregnancy using RU 486 alone or in combination with prostaglandin. Zhonghua Fu Chan Ke Za Zhi; 25: 31–34, 62.
  6. Cheng L. Medical abortion in early pregnancy: experience in China. Contraception. 2006;74:61–65
  7. Schaff EA, Eisinger SH, Franks P, Kim SS. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med. 1995;4:774–779
  8. Mishell DR, Jain JK, Byrne JD, Lacarra MD. A medical method of early pregnancy termination using tamoxifen and misoprostol. Contraception. 1998;58:1–6
  9. Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception. 2000;61:41–46
  10. Jain JK, Meckstroth KR, Mishell DR. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol. Am J Obstet Gynecol. 1999;181:1386–1391
  11. Walker K, Schaff E, Fielding S, Fuller L. Monitoring serum chorionic gonadotropin levels after mifepristone abortion. Contraception. 2001;64:271–273
  12. Creinin MD. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol. Am J Obstet Gynecol. 1996;174:776–778
  13. Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol. 2003;109:190–195
  14. Creinin MD, Vittinghoff E. Methotrexate and misoprostol vs. misoprostol alone for early abortion. A randomized controlled trial. JAMA. 1994;272:1190–1195
  15. Rørbye C, Nørgaard M, Vestermark V, Nilas L. Medical abortion: defining success and categorizing failures. Contraception. 2003;68:247–251
  16. Acharya G, Haugen M, Bråthen A, Nilsen I, Maltau JM. Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting. Acta Obstet Gynecol Scand. 2004;83:390–394
  17. Winikoff B, Ellertson C, Clark S. Analysis of failure in medical abortion. Contraception. 1996;54:323–327
  18. Parashar P, Iversen OE, Midbøe G, Myking O, Bjørge L. Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness. Eur J Contracept Reprod Health Care. 2007;12:366–371
  19. Allen RH, Westhoff C, De Nonno L, Fielding SL, Schaff EA. Curettage after mifepristone-induced abortion: frequency, timing, and indications. Obstet Gynecol. 2001;98:101–106
  20. Rørbye C, Nørgaard M, Nilas L. Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomized study. Hum Reprod. 2005;20:834–838
  21. Kruse B, Poppema S, Creinin MD, Paul M. Management of side effects and complication in medical abortion. Am J Obstet Gynecol. 2000;183:S65–S75
  22. Harwood B, Meckstroth KR, Mishell DR, Jain JK. Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion. Contraception. 2001;63:255–256
  23. Wong SF, Lam MH, Ho LC. Transvaginal sonography in the detection of retained products of conception after first-trimester spontaneous abortion. J Clin Ultrasound. 2002;30:428–432
  24. Chen Y, Ma Q, Yi N. The influence of the size of embryo sac by ultrasound measurement on the result of termination of early pregnancy with RU486 and misoprostol. Chin J Fam Plann. 1993;6:352–353
  25. Godfrey EM, Anderson A, Fielding SL, Meyn L, Creinin MD. Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited. Contraception. 2007;75:378–382
  26. Thonneau P, Fougeyrollas B, Spira A. Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center. Fertil Steril. 1994;61:627–631
  27. Honkanen H, Ranta S, Ylikorkala O, Heikinheimo O. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy. Hum Reprod. 2002;17:2315–2319

☆ The study was funded by the Foundation of Nature Science of Shandong Province (2006BS3038) and the Foundation of Nature Science of China (30700163).

PII: S0010-7824(09)00423-5

doi: 10.1016/j.contraception.2009.09.013

Contraception
Volume 81, Issue 1 , Pages 62-66 , January 2010

Article Tools